Production (Stage)
Fractyl Health, Inc.
GUTS
$2.27
$0.115.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 3.00K | 14.00K | 43.00K | 33.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 3.00K | 14.00K | 43.00K | 33.00K |
| Cost of Revenue | -- | 0.00 | 7.00K | 24.00K | 19.00K |
| Gross Profit | -- | 3.00K | 7.00K | 19.00K | 14.00K |
| SG&A Expenses | 5.32M | 4.93M | 4.80M | 6.24M | 7.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.76M | 25.21M | 23.81M | 23.03M | 21.58M |
| Operating Income | -24.76M | -25.21M | -23.79M | -22.99M | -21.54M |
| Income Before Tax | -23.74M | -24.97M | -23.17M | -17.23M | -3.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.74M | -24.97M | -23.17M | -17.23M | -3.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.74M | -24.97M | -23.17M | -17.23M | -3.32M |
| EBIT | -24.76M | -25.21M | -23.79M | -22.99M | -21.54M |
| EBITDA | -24.47M | -24.99M | -23.59M | -22.79M | -21.49M |
| EPS Basic | -0.49 | -0.52 | -0.48 | -0.36 | -0.17 |
| Normalized Basic EPS | -0.30 | -0.31 | -0.27 | -0.22 | -0.21 |
| EPS Diluted | -0.49 | -0.52 | -0.48 | -0.36 | -0.17 |
| Normalized Diluted EPS | -0.30 | -0.31 | -0.27 | -0.22 | -0.21 |
| Average Basic Shares Outstanding | 48.87M | 48.45M | 47.97M | 47.90M | 29.74M |
| Average Diluted Shares Outstanding | 48.87M | 48.45M | 47.97M | 47.90M | 29.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |